Cite

HARVARD Citation

    White, P. et al. (2018). A phase I study of anti‐inflammatory therapy with rilonacept in adolescents and adults with type 1 diabetes mellitus. Pediatric diabetes. 19 (4), pp. 788-793. [Online]. 
  
Back to record